PE20011064A1 - Eteres de dicarboxilato de calcio y metodos para su preparacion - Google Patents

Eteres de dicarboxilato de calcio y metodos para su preparacion

Info

Publication number
PE20011064A1
PE20011064A1 PE2001000076A PE2001000076A PE20011064A1 PE 20011064 A1 PE20011064 A1 PE 20011064A1 PE 2001000076 A PE2001000076 A PE 2001000076A PE 2001000076 A PE2001000076 A PE 2001000076A PE 20011064 A1 PE20011064 A1 PE 20011064A1
Authority
PE
Peru
Prior art keywords
calcium
formula
refers
preparation
mono
Prior art date
Application number
PE2001000076A
Other languages
English (en)
Spanish (es)
Inventor
Howard Yoshihisa Ando
Gary Jay Dozeman
Donald Eugene Butler
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of PE20011064A1 publication Critical patent/PE20011064A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/235Saturated compounds containing more than one carboxyl group
    • C07C59/305Saturated compounds containing more than one carboxyl group containing ether groups, groups, groups, or groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
PE2001000076A 2000-01-25 2001-01-24 Eteres de dicarboxilato de calcio y metodos para su preparacion PE20011064A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17782300P 2000-01-25 2000-01-25

Publications (1)

Publication Number Publication Date
PE20011064A1 true PE20011064A1 (es) 2001-10-22

Family

ID=22650106

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2001000076A PE20011064A1 (es) 2000-01-25 2001-01-24 Eteres de dicarboxilato de calcio y metodos para su preparacion

Country Status (39)

Country Link
EP (1) EP1259474B1 (enExample)
JP (1) JP4750995B2 (enExample)
KR (1) KR20020073182A (enExample)
CN (1) CN1395555A (enExample)
AP (1) AP2002002587A0 (enExample)
AR (1) AR029436A1 (enExample)
AT (1) ATE431326T1 (enExample)
AU (1) AU2214001A (enExample)
BG (1) BG106851A (enExample)
BR (1) BR0107763A (enExample)
CA (1) CA2397960C (enExample)
CO (1) CO5261537A1 (enExample)
CZ (1) CZ20022474A3 (enExample)
DE (1) DE60138686D1 (enExample)
DK (1) DK1259474T3 (enExample)
DZ (1) DZ3239A1 (enExample)
EA (1) EA004862B1 (enExample)
EE (1) EE200200404A (enExample)
ES (1) ES2324281T3 (enExample)
GE (1) GEP20053428B (enExample)
GT (1) GT200100015A (enExample)
HN (1) HN2001000011A (enExample)
HU (1) HUP0204422A3 (enExample)
IL (1) IL150541A0 (enExample)
IS (1) IS6442A (enExample)
MA (1) MA26867A1 (enExample)
MX (1) MXPA02007223A (enExample)
NO (1) NO20023526L (enExample)
NZ (1) NZ519550A (enExample)
OA (1) OA12166A (enExample)
PA (1) PA8510601A1 (enExample)
PE (1) PE20011064A1 (enExample)
PL (1) PL357076A1 (enExample)
SK (1) SK10622002A3 (enExample)
SV (1) SV2002000290A (enExample)
TN (1) TNSN01013A1 (enExample)
UY (1) UY26550A1 (enExample)
WO (1) WO2001055078A1 (enExample)
ZA (1) ZA200205880B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1481962A1 (en) * 1997-12-12 2004-12-01 Warner-Lambert Company LLC New cholesterolemia-lowering carboxyalkylether compound
WO2004017952A1 (en) * 2002-08-22 2004-03-04 Warner-Lambert Company Llc Method of treating osteoarthritis
CN101163668A (zh) * 2005-04-19 2008-04-16 卫材R&D管理有限公司 双[(2s)-3-[3-(2s)-3-(4-氯-2-氰基苯氧基)-2-氟丙氧基]苯基]-2-异丙氧基丙酸]钙及其中间体
US7816405B2 (en) 2005-04-19 2010-10-19 Eisai R&D Management Co., Ltd. Calcium bis [(2S)-3-[3-[(2S)-3-(4-chloro-2-cyanophenoxy)-2-fluoropropoxy]phenyl ]-2-isopropoxypropionate] and intermediate thereof
WO2016077832A2 (en) * 2014-11-14 2016-05-19 Gemphire Therapeutics Inc. PROCESSES AND INTERMEDIATES FOR PREPARING α,ω-DICARBOXYLIC ACID-TERMINATED DIALKANE ETHERS
CA3059073A1 (en) * 2017-04-18 2018-10-25 Daniela Carmen Oniciu Gemcabene, pharmaceutically acceptable salts thereof, compositions thereof and methods of use therefor
CN113396138A (zh) * 2018-10-18 2021-09-14 燿石治疗公司 吉卡宾、其药学上可接受的盐、其组合物和其使用方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5648387A (en) * 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
NZ503982A (en) 1997-12-12 2002-03-28 Warner Lambert Co Statin-carboxyalkylether combinations useful for treating vascular disorders and diabetes mellitus

Also Published As

Publication number Publication date
JP2003520835A (ja) 2003-07-08
UY26550A1 (es) 2001-08-27
CA2397960C (en) 2008-09-09
GT200100015A (es) 2001-10-19
EP1259474A1 (en) 2002-11-27
WO2001055078A1 (en) 2001-08-02
ES2324281T3 (es) 2009-08-04
NO20023526D0 (no) 2002-07-24
DE60138686D1 (de) 2009-06-25
MA26867A1 (fr) 2004-12-20
SK10622002A3 (sk) 2003-07-01
AU2214001A (en) 2001-08-07
EA004862B1 (ru) 2004-08-26
DZ3239A1 (fr) 2001-08-02
GEP20053428B (en) 2005-01-25
MXPA02007223A (es) 2002-11-29
PL357076A1 (en) 2004-07-12
EA200200641A1 (ru) 2002-12-26
KR20020073182A (ko) 2002-09-19
JP4750995B2 (ja) 2011-08-17
EE200200404A (et) 2003-10-15
CZ20022474A3 (cs) 2003-06-18
EP1259474B1 (en) 2009-05-13
ZA200205880B (en) 2003-07-23
ATE431326T1 (de) 2009-05-15
SV2002000290A (es) 2002-07-16
IS6442A (is) 2002-06-25
IL150541A0 (en) 2003-02-12
CA2397960A1 (en) 2001-08-02
PA8510601A1 (es) 2002-08-26
CO5261537A1 (es) 2003-03-31
HUP0204422A2 (en) 2003-05-28
NZ519550A (en) 2003-11-28
BR0107763A (pt) 2002-11-12
DK1259474T3 (da) 2009-07-20
AP2002002587A0 (en) 2002-09-30
AR029436A1 (es) 2003-06-25
BG106851A (en) 2003-01-31
CN1395555A (zh) 2003-02-05
TNSN01013A1 (fr) 2005-11-10
HUP0204422A3 (en) 2003-08-28
NO20023526L (no) 2002-08-27
HN2001000011A (es) 2001-06-13
OA12166A (en) 2003-11-07

Similar Documents

Publication Publication Date Title
DE69230755T2 (de) Porphycenverbindungen zur photodynamischen therapie
AR041932A1 (es) Derivados de ciclohexano espirociclicos, preparacion de los mismos, su uso en la fabricacion de medicamentos y dichos medicamentos.
DE60103697T2 (de) Langwelligabsorbierende Bacteriochlorin-Alkyl-Aether- Analoge
EA200300211A1 (ru) Азабициклические соединения, способ их получения и их применение в качестве лекарственных средств, в частности в качестве антибактериальных средств
ATE557009T1 (de) Sulfonsubstituierte chinazolinderivative als immunmodulatoren zur behandlung von enzündlichen und allergischen erkrankungen
PE20011064A1 (es) Eteres de dicarboxilato de calcio y metodos para su preparacion
ES8705385A1 (es) Procedimiento para preparar isomeros de derivados de prostaglandina
US10815254B2 (en) Biflavone-zinc complex, preparation method and application thereof
ES8200401A1 (es) Un procedimiento para la preparacion de una composicion de un inhibidor de hmg-coa reductasa y un secuestrante de acidosbiliares util para el tratamiento de la hipercolesteremia.
DE2245270C3 (de) Verfahren zur Herstellung von Cyclohexandionen-0,3)
Wang et al. Synthesis of organic nitrates of luteolin as a novel class of potent aldose reductase inhibitors
PE20131327A1 (es) Forma cristalina delta de la sal de arginina de perindoprilo, su procedimiento de preparacion, y las composiciones farmaceuticas que la contienen
AR073807A1 (es) Proceso para preparar el malato de sunitinib, sal de un acido mas debil que el malato como compuesto intermediario, y proceso para preparar dicha sal intermediaria.
SE8005778L (sv) Dermatologisk beredning jemte sett for dess framstellning
BRPI0507422A (pt) processo para produção de ácido 2,5-dimetilfenilacético
WO2008111563A1 (ja) 鉄サラン錯体触媒を用いた光学活性スルホキシド化合物の製造法
CN116850287B (zh) 一种抗菌透明敷贴
CN101880261A (zh) 一种中间体反式-5-(4-氯苯基)-4-甲基-2-氧代噻唑烷酮的合成方法
TW200618815A (en) Manufacturing method for long-term stable L-ascorbic acid cosmetic and its product
CN119409688B (zh) 一种D-π-A型有机抗菌光敏剂及其合成方法和应用
AR034895A1 (es) Una composicion de aditivo alimenticio para animales y un procedimiento para prepararla
EA200800861A1 (ru) Способ получения четвертичных аммониевых солей с кислотой
JPS60155159A (ja) ピリドキシン酸誘導体の製造方法
AT364709B (de) Kosmetische mittel mit bakteriostatischer wirkung
Sadeh et al. The preparation of selenium‐containing aromatic and heterocyclic C‐substituted α‐amino acetic acid derivatives of potential biomedical application

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed